Camp4 Therapeutics Corp
CAMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736730
In the last 90 days, Camp4 Therapeutics Corp insiders filed 5 open-market purchases and 4 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $182.4M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Camp4 Therapeutics Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 5 filings
- 4 insiders, $99.1K in total
- Open-market sells
- 4 filings
- 2 insiders, $2.50M in total
- Insiders trading
- 6
- Net value
- −$2.40M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Camp4 Therapeutics Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Gold Kelly | Chief Financial Officer | 10,000Indirect | Sep 2, 2026 | 4 |
| Schwab Andrew J. | Director | 2,033,270Indirect | Aug 31, 2026 | 5 |
| Tardiff Daniel | Chief Scientific Officer | 0 | Aug 19, 2026 | 3 |
| Parmar Kush | 10% Owner | 2,941,176Indirect | Aug 5, 2026 | 1 |
| 5AM Ventures VI, L.P. | 10% Owner | 2,941,176Indirect | Aug 5, 2026 | 1 |
| 5AM Partners VI, LLC | 10% Owner | 2,941,176Indirect | Aug 5, 2026 | 1 |
| 5AM Opportunities II, L.P. | 10% Owner | 2,941,176Indirect | Aug 5, 2026 | 1 |
| 5AM Ventures VII, L.P. | 10% Owner | 2,941,176Indirect | Aug 5, 2026 | 1 |
| 5AM Opportunities II (GP), LLC | 10% Owner | 2,941,176Indirect | Aug 5, 2026 | 1 |
| 5AM Partners VII, LLC | 10% Owner | 2,941,176Indirect | Aug 5, 2026 | 1 |
| Young Richard A | Director | 186,388 | Aug 5, 2026 | 2 |
| Maricich Yuri | Chief Medical Officer | 12,611 | Aug 5, 2026 | 3 |
| Mandel-Brehm Josh | Chief Executive Officer | 284,968 | Aug 5, 2026 | 3 |
| Williams Douglas E | Director | – | Jun 12, 2026 | 1 |
| Holtzman Steven H | Director | 108,946 | Jun 12, 2026 | 1 |
| Nashat Amir | Director, 10% Owner | 197,661Indirect | Jun 12, 2026 | 1 |
| Stewart Murray | Director | – | Jun 12, 2026 | 1 |
| MacLean Michael F | Director | – | Apr 3, 2026 | 1 |
| Chee Brian | 10% Owner | 197,661Indirect | Sep 11, 2025 | 0 |
| Schulman Amy W | 10% Owner | 197,661Indirect | Sep 11, 2025 | 0 |
| Polaris Partners VII, L.P. | 10% Owner | 197,661Indirect | Sep 11, 2025 | 0 |
| Polaris Entrepreneurs' Fund VII, L.P. | 10% Owner | 197,661Indirect | Sep 11, 2025 | 0 |
| Polaris Management Co. VII, L.L.C. | 10% Owner | 197,661Indirect | Sep 11, 2025 | 0 |
| Polaris Partners GP X, L.L.C. | 10% Owner | 197,661Indirect | Sep 11, 2025 | 0 |
| Polaris Partners X, L.P. | 10% Owner | 197,661Indirect | Sep 11, 2025 | 0 |
| Higgins Michael J | Director | – | Jun 27, 2025 | 0 |
| Ragan Paula | Director | – | Jun 27, 2025 | 0 |
| Boylan James P | Director | – | Jun 27, 2025 | 0 |
| Thadhani Ravi I. | Director | – | Jun 27, 2025 | 0 |
| Bumcrot David | Chief Scientific Officer | – | Apr 3, 2025 | 0 |
| Northpond Ventures GP, LLC | 10% Owner | 763,636Indirect | Oct 17, 2024 | 0 |
| Northpond Ventures, LP | 10% Owner | 763,636Indirect | Oct 17, 2024 | 0 |
| Rubin Michael P. | 10% Owner | 763,636Indirect | Oct 17, 2024 | 0 |
| Northpond Ventures II GP, LLC | 10% Owner | 763,636Indirect | Oct 17, 2024 | 0 |
| Northpond Ventures II, LP | 10% Owner | 763,636Indirect | Oct 17, 2024 | 0 |
| Northpond Ventures III, LP | 10% Owner | 763,636Indirect | Oct 17, 2024 | 0 |
| Northpond Ventures III GP, LLC | 10% Owner | 763,636Indirect | Oct 17, 2024 | 0 |
| Andreessen Marc L | 10% Owner | 545,454Indirect | Oct 17, 2024 | 0 |
| Horowitz Benjamin A | 10% Owner | 545,454Indirect | Oct 17, 2024 | 0 |
| AH Equity Partners Bio I, L.L.C. | 10% Owner | 545,454Indirect | Oct 17, 2024 | 0 |
| AH Bio Fund I, L.P. | 10% Owner | 545,454Indirect | Oct 17, 2024 | 0 |
| AH Bio Fund IV, L.P. | 10% Owner | 545,454Indirect | Oct 17, 2024 | 0 |
| AH Equity Partners Bio IV, L.L.C. | 10% Owner | 545,454Indirect | Oct 17, 2024 | 0 |
| Enavate Sciences GP, LLC | 10% Owner | 3,785,802Indirect | Oct 17, 2024 | 0 |
| Everest Aggregator, LP | 10% Owner | 3,785,802Indirect | Oct 17, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 (view filing)7:50 PM ET | Aug 31 | 2 days | Gold KellyChief Financial Officer | PPurchase | +10.0K | $3.96 | +$39.6K | New position10.0K after | |
| Aug 31, 2026 (view filing)5:05 PM ET | Aug 27 | 4 days | Schwab Andrew J.Director | SSale | −400.0K | $4.04 | −$1.62M | −16.4%2.03M after | |
| Aug 26, 2026 (view filing)4:57 PM ET | Aug 24 | 2 days | Schwab Andrew J.Director | SSale | −10 | $4.50 | −$45 | 0.0%2.43M after | |
| Aug 21, 2026 (view filing)4:59 PM ET | Aug 19-21 | 2 days | Schwab Andrew J.Director | SSale | −191.9K | $4.59 | −$879.7K | −7.3%2.43M after | 3 lots |
| Aug 19, 2026 (view filing)8:46 PM ET | Aug 19 | Same day | Tardiff DanielChief Scientific Officer | SSale | −1.74K | $4.76 | −$8.27K | −100.0%0 after | |
| Aug 5, 2026 (view filing)5:39 PM ET | Aug 3 | 2 days | Parmar Kush and 6 others10% Owner | PPurchase | +3.18M | $1.53 | +$4.86M | –3.18M after | Derivative |
| Aug 5, 2026 (view filing)5:09 PM ET | Aug 3 | 2 days | Young Richard ADirector | PPurchase | +16.4K | $1.65 | +$27.0K | +9.6%186.4K after | |
| Aug 5, 2026 (view filing)5:08 PM ET | Aug 3 | 2 days | Maricich YuriChief Medical Officer | PPurchase | +6.55K | $1.65 | +$10.8K | +108.1%12.6K after | |
| Aug 5, 2026 (view filing)5:08 PM ET | Aug 3 | 2 days | Gold KellyChief Financial Officer | PPurchase | +6.55K | $1.65 | +$10.8K | +9.7%74.4K after | |
| Aug 5, 2026 (view filing)5:07 PM ET | Aug 3 | 2 days | Mandel-Brehm JoshChief Executive Officer | PPurchase | +6.55K | $1.65 | +$10.8K | +2.4%285.0K after | |
| Sep 15, 2025 (view filing)8:12 PM ET | Sep 11 | 4 days | Parmar Kush and 6 others10% Owner | PPurchase | +2.94M | $1.53 | +$4.50M | New position2.94M after | |
| Sep 11, 2025 (view filing)4:59 PM ET | Sep 11 | Same day | Chee Brian and 6 others10% Owner | PPurchase | +1.31M | $1.53 | +$2.00M | New position197.7K after | 2 lotsDuplicate filing |
| Sep 11, 2025 (view filing) | Sep 11 | Same day | Gold KellyChief Financial Officer | PPurchase | +6.06K | $1.65 | +$10.0K | +9.8%67.9K after | |
| Sep 11, 2025 (view filing) | Sep 11 | Same day | Mandel-Brehm JoshChief Executive Officer | PPurchase | +6.06K | $1.65 | +$10.0K | +2.2%278.4K after | |
| Sep 11, 2025 (view filing) | Sep 11 | Same day | Maricich YuriChief Medical Officer | PPurchase | +6.06K | $1.65 | +$10.0K | New position6.06K after | |
| Sep 11, 2025 (view filing) | Sep 11 | Same day | Young Richard ADirector | PPurchase | +15.2K | $1.65 | +$25.0K | +9.8%170.0K after | |
| Sep 11, 2025 (view filing) | Sep 11 | Same day | Nashat AmirDirector, 10% Owner | PPurchase | +1.31M | $1.53 | +$2.00M | New position197.7K after | 2 lots |
| Oct 22, 2024 (view filing)5:31 PM ET | Oct 15 | 7 days | Chee Brian and 6 others10% Owner | PPurchase | +909.1K | $11.00 | +$10.0M | New position909.1K after | AmendedDuplicate filing |
| Oct 17, 2024 (view filing)6:34 PM ET | Oct 15 | 2 days | Northpond Ventures GP, LLC and 6 others10% Owner | PPurchase | +763.6K | $11.00 | +$8.40M | New position763.6K after | |
| Oct 17, 2024 (view filing)5:05 PM ET | Oct 15 | 2 days | Andreessen Marc L and 5 others10% Owner | PPurchase | +727.3K | $11.00 | +$8.00M | New position545.5K after | 2 lots |
| Oct 17, 2024 (view filing)4:15 PM ET | Oct 15 | 2 days | Enavate Sciences GP, LLC and 1 other10% Owner | PPurchase | +1.36M | $11.00 | +$15.0M | +56.3%3.79M after | |
| Oct 15, 2024 (view filing)6:00 PM ET | Oct 15 | Same day | Schulman Amy W and 5 others10% Owner | PPurchase | +909.1K | $11.00 | +$10.0M | New position909.1K after | Duplicate filing |
| Oct 15, 2024 (view filing)5:56 PM ET | Oct 15 | Same day | Parmar Kush and 4 others10% Owner | PPurchase | +909.1K | $11.00 | +$10.0M | +53.0%2.63M after | Duplicate filing |
| Oct 15, 2024 (view filing) | Oct 15 | Same day | Nashat AmirDirector, 10% Owner | PPurchase | +909.1K | $11.00 | +$10.0M | New position909.1K after | |
| Oct 15, 2024 (view filing) | Oct 15 | Same day | Schwab Andrew J.Director, 10% Owner | PPurchase | +909.1K | $11.00 | +$10.0M | +53.0%2.63M after |